Physician profile
Ryan J Broyles
NPI 1750548871
$4,653.78
in general payments reported to CMS, 2019-2025
19 companies · $754 in 2025
The $754 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $569 · 2021: $380 · 2022: $1,286 · 2023: $433 · 2024: $496 · 2025: $754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,683.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $763.29 | 2019-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $723.98 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $589.47 | 2022-2025 | Tyrvaya |
| Bausch & Lomb Americas INC. | $404.84 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $380.91 | 2019 | |
| Allergan, INC. | $293.51 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $270.71 | 2020-2023 | |
| Glaukos Corporation | $244.11 | 2020-2021 | |
| Coopervision INC. | $187.90 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens |
| Sight Sciences, INC. | $186.57 | 2022 | |
| Alcon Vision LLC | $159.46 | 2019-2025 | Precision7, Total30, Precision 1 |
| Abb Con-Cise Optical Group LLC | $136.58 | 2019 | |
| Rxsight INC | $91.93 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Tarsus Pharmaceuticals, INC. | $68.79 | 2024-2025 | Xdemvy |
| The Cameron-Ehlen Group, INC. | $60.38 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $20.83 | 2024 | Clarus |
| Kala Pharmaceuticals, INC. | $17.03 | 2021 | |
| Mallinckrodt Hospital Products INC. | $14.69 | 2024 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Broyles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.